ArticleJournal of hepatocellular carcinoma2023

Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma.

Bingran Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.